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Chris Platania-Phung3, Karen-leigh Edward4,5 and David Castle5,6,7Abstract
Background: People with serious mental illness (SMI) exhibit a high prevalence of cardiovascular diseases. Mental
health services have a responsibility to address poor physical health in their consumers. One way of doing this is to
conduct metabolic monitoring (MM) of risk factors for cardiovascular diseases. This study compares two models of
MM among consumers with SMI and describes referral pathways for those at high risk of cardiovascular diseases.
Methods: A retrospective cross-sectional comparison design was used. The two models were: (1) MM integrated
with case managers, and (2) MM integrated with case managers and specialist roles. Retrospective data were
collected for all new episodes at two community mental health services (CMHS) over a 12-month period
(September 2012 – August 2013).
Results: A total of 432 consumers with SMI across the two community mental health services were included in the
analysis. At the service with the specialist roles, MM was undertaken for 78% of all new episode consumers,
compared with 3% at the mental health service with case managers undertaking the role. Incomplete MM was
systemic to both CMHS, although all consumers identified with high risk of cardiovascular diseases were referred to
a general practitioner or other community based health services. The specialist roles enabled more varied referral
options.
Conclusions: The results of this study support incorporating specialist roles over case manager only roles for more
effective MM among new episode consumers with SMI.
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People with serious mental illness (SMI: psychotic
illnesses primarily schizophrenia spectrum or bipolar
affective disorder) have a reduced life expectancy com-
pared with the general population [1]. People with SMI
exhibit a substantially higher prevalence of co-existing
conditions such as cardiovascular diseases [1] and its
precursor, metabolic syndrome [2,3]. Such is the sub-
optimal combination of mental and physical health that
the risk of cardiovascular diseases alone, is between two* Correspondence: brian.mckenna@mh.org.au
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unless otherwise stated.[2] and 12 times greater among people with SMI than
the general population [4]. Australian mental health ser-
vices have a responsibility to address poor physical
health [5], and this will involve a shift in provider cul-
ture, practice, and service delivery [6].
A necessary process in the shift of provider practice is
to conduct metabolic monitoring (MM). Such monito-
ring involves quantifying risk factors for cardiovascular
diseases such as blood pressure, cholesterol, blood sugar
levels, waist and hip circumference, and body mass and
stature [6,7], along with modifiable lifestyle behaviours
(e.g., tobacco smoking, alcohol consumption, physical
activity, and nutrition) and antipsychotic medication
prescription. However, selecting and implementing a
MM model can be problematic due to perceptions ofal Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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pessimism persists about the effect of healthy lifestyle
recommendations post MM on consumer behaviours [1]
and health outcomes [11].
The principle aim of effective MM of people with SMI
is to obtain metabolic information that can be used to
tailor physical health interventions [12]. However, a
generic MM model may be challenged by the aforemen-
tioned reasons [12]. Furthermore, effectiveness of MM
has not been described with randomised controlled trials
at this time [12]. Therefore, clinicians are without a clear
MM model and confusion among who is responsible for
MM (i.e., primary or secondary care) persists [13,14].
Despite evidence supporting the need for MM of
people with SMI and the development of clinical guide-
lines for the physical health care of consumers [15-17],
the process of monitoring is often incomplete [6,18,19].
Incomplete monitoring implies poor identification of
cardiovascular diseases risk factors [20,21] and subse-
quent increased morbidity [17]. Furthermore, adequate
and responsible referral once risk has been identified
should also supplement MM as a fundamental com-
ponent in addressing identified risks [22,23], cognisant
of the reported communication barriers among mental
health and community health services [24].
Given the known risk of people with SMI to car-
diovascular diseases, more knowledge is needed about
the effectiveness of MM models and associated referral
pathways for high risk consumers to inform future phy-
sical health policy across mental health services. There-
fore, the aims of this study were to; (1) describe the
effectiveness of MM and scope of referral pathways
within one of Australia’s largest mental health services,
and (2) compare MM in an area with specialist MM
roles with an area reliant of existing case manager roles.
Methods
Setting
Responding to the challenges of effective MM, one of
Australia’s largest mental health services introduced a
MM policy to improve the early detection, treatment,
and use of referral pathways among consumers with
SMI. The policy initiative was coupled with staff educa-
tion that occurred across all community mental health
services (CMHS) in 2011–12. Metabolic monitoring was
supported with the provision of a generic MM data col-
lection form and a risk identification/referral pathway
algorithm. The identification of risk was based on
national (e.g., Heart Foundation [25]) and international
(e.g., World Health Organization [26]) guidelines. As
such, the responsibility for MM and associated referral
pathways was integrated into existing case manager roles
for all CMHS. As per the MM policy, medical staff and
case managers have the shared responsibility to ensurethat each consumer has had MM. Furthermore, case
managers should support consumers to access appro-
priate investigations and treatments including facilitating
attendance to general practitioners or other medical
appointments. In the instance of detected high risk of
cardiovascular diseases, the case manager should facili-
tate referral to and attendance at the consumer’s general
practitioner. The procedure for collection of MM in-
formation in line with the service policy is for case
managers to collect data (e.g., body mass and blood
pressure), which is recorded on the generic MM data
collection form. Case managers are required to facilitate
medical investigations such as collection of bloods for
fats and sugar investigations.
In addition, one CMHS saw value in developing spe-
cialist roles within existing mental health nursing staff
resource to support case managers undertaking MM and
physical health assessment of consumers. The equivalent
of 0.5 EFT of Registered Nurse and 0.8 EFT Enrolled
Nurse was allocated to focus on supporting case ma-
nagers undertake MM and to ensure the form has been
completed and missing information is updated.
Design
A retrospective cross-sectional comparison study was
undertaken to address the research aims. Two CMHS
within the mental health service were selected for com-
parison; (1) a CMHS with the specialist MM roles and
(2) a CMHS with the responsibility for MM resting with
case managers. The populations of both CMHS catch-
ment areas are characterised with low socio-economic
status and high immigrant and ethnic diversity com-
pared with the remainder of the state of Victoria. All
new consumer episodes referred to each CMHS for the
first time, inclusive of September 2012 to August 2013
were assessed for MM data. A retrospective electronic
file audit was undertaken and data were collected based
on the presence of the aforementioned generic MM data
collection form. The absence of the form was indicative
of MM not having been undertaken. From the form, the
presence of monitoring specific risk factors of cardiovas-
cular diseases was determined. The MM variables were
body mass index, fasting blood glucose, blood pressure,
waist circumference, total cholesterol, triglycerides, low
density lipoprotein level, high density lipoprotein level,
exercise status, and smoking status. Metabolic moni-
toring outcome variables were categorised for cardio-
vascular diseases risk as ‘high risk’, ‘moderate risk’, and
‘low risk’ in accordance with national and international
guidelines. The scope of referral pathways were de-
scribed relative to primary health and preventative
health providers. The conduct of the study was ethically
approved by the Melbourne Health Office for Research
(QA2013174).
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Descriptive statistics were computed for consumer
demographics, MM variables, and referral pathways. A
univariate Chi-square (χ2) analysis was conducted to
compare the difference among frequency counts of the
generic MM data collection form across the two CMHS
with Statistical Package for Social Scientists 20.0 for
Windows (IBM Corp, Armonk, USA). Significance was
accepted at p ≤ 0.05.
Results
A total of 432 new episode consumers were eligible for
MM across the two CMHS (see Table 1). The samples
were evenly matched according to gender. Consumer
age range was 19 years to 65 years. Most consumers
were diagnosed with a psychotic illness (schizophrenia,
schizoaffective disorder, or psychotic illness unspecified).
At the CMHS with specialist roles, MM was undertaken
for 105 (78%) of 134 new episode consumers. At the
CMHS with case manager only roles, MM was under-
taken for 8 (3%) of the 298 new episodes, χ2(1, N = 113) =
83.27, p = 0.01.
At the CMHS with the specialist MM roles smoking
status, exercise frequency, low density lipoprotein level,
and waist circumference were the most common ‘high
risk’ variables for cardiovascular diseases (see Table 2).
Of new episode consumers that were metabolically
monitored at the specialist roles CMHS, the range of
monitoring of outcome variables was 53% (low density
lipoprotein) to 100% (smoking status). At the CMHS
with case managers responsible for undertaking MM, a
lack of effectiveness of MM was found.Table 1 Sample descriptors (N = 432) across the two
CMHS
SR1 CMHS CM2 CMHS
(n = 134) (n = 298)
Gender (%) Male 67 (50) 159 (53)
Female 67 (50) 139 (47)
Age (years) Male mean (SD) 38 (11) 38 (10)
Range 19-63 19-64
Female mean (SD) 38 (11) 41 (12)
Range 18-64 20-65
Diagnosis (%) Psychotic illness3 84 (63) 188 (63)
Bipolar affective
disorder unspecified
18 (12) 22 (7)
Major depression 3 (2) 17 (6)
Other diagnosis4 31 (23) 71 (24)
NOTE: SR CMHS case manager EFT = 10.6. CM CMHS case manager EFT = 17.4.
1Specialist roles.
2Case manager only roles.
3Schizophrenia, schizoaffective disorder, psychotic disorder unspecified.
4Other ICD-10-AM ‘F’ codes.Of new episode consumers who underwent MM
(n = 113), referral pathways were established for each
identified as ‘high risk’ of cardiovascular diseases across
both CMHS. Referral pathways at the specialist roles
CMHS included; a dietician, an exercise physiologist, a
well women’s group, a diabetic educator, a podiatrist,
council initiatives (Jamie's Ministry of Food and a leisure
programme), a YMCA exercise programme, a Quit
programme for smoking cessation, a volunteer fitness
instructor, and general practitioners. The referral path-
way at the CMHS with case manager only roles was to
each consumer’s general practitioner.
Discussion
The results of this study underline the importance of
specialist roles to more effectively support MM in
CMHS. In this study, specialist roles were able to
document varying levels of cardiovascular diseases risk
among 78% of new episode consumers compared with
3% at the CMHS where MM was a usual work task of
case managers. These results support the opinions of
many clinicians; that an individual should be tasked with
MM within mental health services and that extra dis-
crete resourcing is required [27-29]. However, the spe-
cialist roles described in the current study were created
by reconfiguring existing mental health nursing roles ra-
ther than a requirement of additional resource incurred
by the CMHS.
Despite specialist roles in the current study, smoking
status was the only outcome variable with complete
monitoring among all 113 new episode consumers with
SMI. Gaps were found in the reporting of specific risk
factors, despite the gains made in undertaking MM with
the total caseload. These findings support literature
describing the absence or neglect of blood pressure [24],
waist circumference, and body mass monitoring [6].
Retrospective informal discussion with the specialist role
mental health nurses revealed several factors limiting
thorough and systemic MM at the CMHS; poor adher-
ence to blood profiling attributed to consumer anxiety
towards needles, procedural complexity in collecting
fasting blood glucose, the logistical barriers to attending
community based pathology services, and poor commu-
nication between the mental health service and local
medical officers regarding the transfer of diagnostic re-
sults. Similar opinions have been expressed and reported
in previous research [28,30-32]. Acuity among some
consumers and refusal to consent to participate in MM
were also discussed and are commonly identified as po-
tential barriers to MM [33].
Additional barriers to completing MM have included
across-discipline confusion about who should be respon-
sible for the role [6,11,28] and a lack of supporting pro-
cedures [23]. Furthermore, MM has also been limited by
Table 2 Metabolic monitoring risk outcomes of new episode consumers across the two CMHS
Metabolic monitoring outcome variables at the CMHS with specialist roles Cardiovascular diseases risk factors
(n = 105) n (%)
High Moderate Low Missing
Body mass index1 21 (30) 22 (31) 27 (39) 35
Fasting blood glucose2 5 (8) 12 (20) 44 (72) 44
Blood pressure3 2 (3) 4 (6) 59 (91) 40
Waist circumference4 33 (51) 16 (24.5) 16 (24.5) 40
Total cholesterol5 24 (36) - 42 (64) 39
Triglycerides6 23 (35) - 43 (65) 39
Low density lipoproteins7 37 (66) - 19 (34) 49
High density lipoproteins8 5 (9) - 52 (96) 48
Exercise status9 44 (76) - 14 (24) 47
Smoking status10 34 (32) - 71 (68) 0
Metabolic monitoring outcome variables at the CMHS with case manager only roles Cardiovascular diseases risk factors
(n = 8) n 11
High Moderate Low Missing
Body mass index 2 2 3 1
Fasting blood glucose 0 1 4 3
Blood pressure 0 2 5 3
Waist circumference 3 1 0 4
Total cholesterol 3 - 1 4
Triglycerides 0 - 2 6
Low density lipoproteins 2 - 2 4
High density lipoproteins 1 - 2 5
Exercise status 4 - 1 3
Smoking status 7 - 0 1
1High > 30 kg.m−2, Moderate 25–30 kg.m−2, Low < 25 kg.m−2.
2High 7.0 mmol.L−1, Moderate 5.5-6.9 mmol.L−1, Low < 5.5 mmol.L−1.
3High > 180 mm.Hg−1 systolic and > 110 mm.Hg−1 diastolic, Moderate 140-180 mm.Hg−1 systolic and 90–110 mm.Hg−1, Low < 140 mm.Hg−1 systolic
and < 90 mm.Hg−1.
4High female ≥ 88 cm, male ≥ 102 cm, Moderate female ≥ 80 cm, male ≥ 94 cm, Low female < 80 cm, male < 94 cm.
5High > 5.5 mmol.L−1, Low ≤ 5.5 mmol.L−1.
6High > 2.0 mmol.L−1, Low ≤ 2.0 mmol.L−1.
7High > 2.5 mmol.L−1, Low ≤ 2.5 mmol.L−1.
8High < 1.0 mmol.L−1, Low ≥ 1.0 mmol.L−1.
9High < every day, Low = every day.
10High = current smoker, Low = does not smoke.
11Percentage not reported for the case manager only roles CMHS due to low n.
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barriers may explain the poor MM at the CMHS in this
study, where the responsibility of monitoring relied on
case managers completing the process as specified in the
service policy. Regardless of the consumer and service
barriers, the volume of missing data among consumers
with SMI in the current study is alarming considering
the number of consumers identified at high risk of car-
diovascular diseases.
The scope of referral pathways for high risk consumers
in this study provided evidence of collaboration with pri-
mary health and preventative health providers. For the
CMHS without specialist roles, referral followed servicepolicy (i.e., to the consumer’s general practitioner). For the
CMHS with specialist roles, referral pathways were tailored
to the MM risk factor identified. These results support the
importance of tailored referral pathways established by a
specialist nurse role in the United Kingdom [23]. Referrals
to physical activity and body mass management groups
[23,34] and one-to-one tailored health interventions [35]
have been effective in eliciting positive lifestyle changes
among consumers with SMI.
Future research should focus on mental health services
developing strategies to engage consumers with MM, so
that all recommended cardiovascular diseases risks are
disclosed. Furthermore, given the emerging knowledge
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SMI [34,35], guidance is also required about efficacy of
interventions to reduce cardiovascular diseases risk once
MM is systemic to mental health services.
Limitations
This study was delimited to the comparison of two CMHS
within one of Australia’s largest mental health services. A
more thorough understanding of the effectiveness of the
MM policy within the mental health service could be de-
scribed if all CMHS were retrospectively audited. Further-
more, we are only able to anecdotally speculate why MM
did not occur for 22% of consumers at the specialist roles
CMHS and 97% of consumers at the case manager roles
CMHS. This study focused on two aims; (1) effectiveness
of two MM models and (2) referral pathways of con-
sumers identified at high risk of cardiovascular diseases.
Given that the specialist roles occurred within existing
budget and required a re-configuration of existing mental
health nursing roles, there is no indication of the impact
of the re-configuration on overall service delivery.
Conclusions
The results of this study support CMHS specialist roles
over case manager only roles for more effective MM
among new episode consumers with SMI. The specialist
roles were also able to provide consumers with more tai-
lored referral options.
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